These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29459985)

  • 1. When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review.
    Savica R; Boeve BF; Mielke MM
    JAMA Neurol; 2018 Apr; 75(4):503-509. PubMed ID: 29459985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
    JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifelong constipation in Parkinson's disease and other clinically defined alpha-synucleinopathies: A population-based study in Southeast Minnesota.
    Camerucci E; Mullan AF; Bower JH; Bharucha AE; Turcano P; Stang CD; Benarroch EE; Boeve BF; Ahlskog JE; Savica R
    Parkinsonism Relat Disord; 2023 Feb; 107():105244. PubMed ID: 36630736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.
    Schenck CH; Boeve BF; Mahowald MW
    Sleep Med; 2013 Aug; 14(8):744-8. PubMed ID: 23347909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches in Parkinson's disease and related disorders.
    Valera E; Masliah E
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):346-352. PubMed ID: 26749150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology underlying clinical variability in patients with synucleinopathies.
    Halliday GM; Holton JL; Revesz T; Dickson DW
    Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synucleinopathy phenotypes.
    McCann H; Stevens CH; Cartwright H; Halliday GM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S62-7. PubMed ID: 24262191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein and Parkinsonism: Updates and Future Perspectives.
    Rosborough K; Patel N; Kalia LV
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):31. PubMed ID: 28324300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
    Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Agents as Potential Drivers of α-Synucleinopathies.
    Linard M; Ravier A; Mougué L; Grgurina I; Boutillier AL; Foubert-Samier A; Blanc F; Helmer C
    Mov Disord; 2022 Mar; 37(3):464-477. PubMed ID: 35040520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
    Peelaerts W; Bousset L; Baekelandt V; Melki R
    Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
    Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
    Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies.
    Fernagut PO; Dehay B; Maillard A; Bezard E; Perez P; Pavy-Le Traon A; Rascol O; Foubert-Samier A; Tison F; Meissner WG
    Neurobiol Dis; 2014 Jul; 67():133-9. PubMed ID: 24727096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging synucleinopathies.
    Brooks DJ; Tambasco N
    Mov Disord; 2016 Jun; 31(6):814-29. PubMed ID: 26879635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.
    VanderHorst VG; Samardzic T; Saper CB; Anderson MP; Nag S; Schneider JA; Bennett DA; Buchman AS
    Ann Neurol; 2015 Jul; 78(1):142-9. PubMed ID: 25893830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.